On Monday, Synopsys, Inc. (NASDAQ:SNPS)’s shares declined -0.42% to $47.68.
Synopsys, Inc. (SNPS) declared that its Board of Directors has replenished its existing stock repurchase authorization back to $500 million.
Synopsys’ Board of Directors originally approved the stock repurchase program in 2002 and has periodically replenished the program as funds are spent. The program does not obligate Synopsys to acquire any particular amount of common stock, and the program may be suspended or terminated at any time at Synopsys’ discretion.
Synopsys, Inc. provides electronic design automation (EDA) software products used to design and test integrated circuits and electronic systems in the United States, Europe, Japan, and the rest of Asia Pacific. Its EDA solutions comprise Galaxy Design platform that provides integrated chip design solution; Verification Continuum Platform, which offers virtual prototyping, static and formal verification, simulation, emulation, field-programmable gate array (FPGA)-based prototyping, and debug; and FPGA design products that are complex chips programmed to perform specific functions.
Stage Stores Inc (NYSE:SSI)’s shares dropped -1.93% to $10.15.
Stage Stores, Inc. (SSI) declared that its Board of Directors has declared a quarterly cash dividend of 15 cents per share on the Company’s common stock, payable on September 16, 2015 to shareholders of record at the close of business on September 1, 2015.
Stage Stores, Inc. operates as a specialty department store retailer in small and mid-sized towns and communities in the United States. Its merchandise portfolio comprises moderately priced brand name and private label apparel, accessories, cosmetics, footwear, and home goods. The company also offers merchandise direct-to-consumer through its ecommerce Website and send program.
At the end of Monday’s trade, XenoPort, Inc. (NASDAQ:XNPT)‘s shares dipped -5.74% to $6.73.
XenoPort, Inc. (XNPT) declared that it will provide access via the World Wide Web to its presentation at the Morgan Stanley Global Healthcare Conference. The live presentation will occur at 11:50 a.m. Pacific Time (2:50 p.m. Eastern Time) on Wednesday, September 16, 2015. A replay of the presentation will also be accessible.
XenoPort, Inc., a biopharmaceutical company, focuses on developing and commercializing a portfolio of product candidates for the treatment of neurological and other disorders. It offers HORIZANT (gabapentin enacarbil) extended-release tablets for the treatment of moderate-to-severe primary restless legs syndrome in adults and for the administration of postherpetic neuralgia in adults.
C.H. Robinson Worldwide, Inc. (NASDAQ:CHRW), ended its Monday’s trading session with -0.12% loss, and closed at $68.60.
C.H. Robinson Worldwide, Inc. (CHRW) declared that its Board of Directors recently declared a regular quarterly cash dividend of 38 cents ($0.38) per share, payable on September 30, 2015, to shareholders of record on September 4, 2015.
C.H. Robinson has distributed regular dividends for more than twenty-five years. As of August 6, 2015, there were about 141,801,035 shares outstanding.
C.H. Robinson Worldwide, Inc., a third party logistics company, provides freight transportation services and logistics solutions to companies in various industries worldwide. It offers transportation and logistics services, such as truckload comprising time-definite and expedited truck transportation services; less than truckload services; intermodal transportation, which is shipment service of freight in trailers or containers by combination of truck and rail; and non-vessel ocean common carrier or freight forwarding services, in addition to organizes air shipments and provides door-to-door services.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
